ID21204A - Proses pembuatan produk-produk amorf dengan bantuan pengeringan konveksi - Google Patents

Proses pembuatan produk-produk amorf dengan bantuan pengeringan konveksi

Info

Publication number
ID21204A
ID21204A IDP981439A ID981439A ID21204A ID 21204 A ID21204 A ID 21204A ID P981439 A IDP981439 A ID P981439A ID 981439 A ID981439 A ID 981439A ID 21204 A ID21204 A ID 21204A
Authority
ID
Indonesia
Prior art keywords
amorf
products
making
convection drying
drying assistance
Prior art date
Application number
IDP981439A
Other languages
English (en)
Inventor
Rolf-Dieter Gabel
Markus Mattern
Gerhard Winter
Alexander Wirl
Heinrich Woog
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ID21204A publication Critical patent/ID21204A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D1/00—Evaporating
    • B01D1/16—Evaporating by spraying
    • B01D1/18—Evaporating by spraying to obtain dry solids
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B3/00—Drying solid materials or objects by processes involving the application of heat
    • F26B3/02—Drying solid materials or objects by processes involving the application of heat by convection, i.e. heat being conveyed from a heat source to the materials or objects to be dried by a gas or vapour, e.g. air
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Microbiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Drying Of Solid Materials (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Glass Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Deposition Of Substances Of Which Semiconductor Devices Are Composed (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IDP981439A 1997-11-03 1998-11-03 Proses pembuatan produk-produk amorf dengan bantuan pengeringan konveksi ID21204A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97119112A EP0913177A1 (de) 1997-11-03 1997-11-03 Verfahren zur Herstellung trockener, amorpher Produkte enthaltend biologisch aktive Materialien mittels Konvektionstrocknung, insbesondere Sprühtrocknung

Publications (1)

Publication Number Publication Date
ID21204A true ID21204A (id) 1999-05-06

Family

ID=8227559

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP981439A ID21204A (id) 1997-11-03 1998-11-03 Proses pembuatan produk-produk amorf dengan bantuan pengeringan konveksi

Country Status (28)

Country Link
US (1) US6689755B1 (id)
EP (1) EP0913177A1 (id)
JP (2) JPH11228389A (id)
KR (1) KR100629378B1 (id)
CN (1) CN1163288C (id)
AR (1) AR015998A1 (id)
AU (1) AU743232B2 (id)
BR (1) BR9804739A (id)
CA (1) CA2253154C (id)
CZ (1) CZ297917B6 (id)
HK (1) HK1020689A1 (id)
HR (1) HRP980575B1 (id)
HU (1) HU221346B1 (id)
ID (1) ID21204A (id)
IL (1) IL126828A0 (id)
MA (1) MA26561A1 (id)
MY (1) MY118853A (id)
NO (1) NO326204B1 (id)
NZ (1) NZ332596A (id)
PE (1) PE127199A1 (id)
PL (1) PL196456B1 (id)
RU (1) RU2233105C2 (id)
SA (1) SA99191068B1 (id)
SG (1) SG66499A1 (id)
TR (1) TR199802204A2 (id)
TW (1) TW575433B (id)
YU (1) YU49598A (id)
ZA (1) ZA9810002B (id)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
EP0913177A1 (de) * 1997-11-03 1999-05-06 Roche Diagnostics GmbH Verfahren zur Herstellung trockener, amorpher Produkte enthaltend biologisch aktive Materialien mittels Konvektionstrocknung, insbesondere Sprühtrocknung
KR100890679B1 (ko) 2000-02-24 2009-03-26 일라이 릴리 앤드 캄파니 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
WO2002000261A2 (en) 2000-06-26 2002-01-03 Monsanto Technology Llc Surfactant-containing formulations for extended release of somatotropin
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
CZ303145B6 (cs) * 2002-01-16 2012-05-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Zpusob výroby dvojvrstevné farmaceutické tablety obsahující telmisartan a hydrochlorthiazid
AU2005254062B2 (en) * 2002-04-11 2011-02-17 Medimmune, Llc High pressure spray-dry of bioactive materials
US7378110B2 (en) * 2002-12-17 2008-05-27 Med Immune Vaccines, Inc. High pressure spray-dry of bioactive materials
HU227041B1 (en) * 2003-03-24 2010-05-28 Richter Gedeon Nyrt Process for the synthesis of amorphous atorvastatin calcium
JP2008509226A (ja) * 2004-05-24 2008-03-27 ジェンボールト コーポレイション 回収可能な形式での安定なタンパク質保管および安定な核酸保管
WO2007016435A2 (en) * 2005-07-28 2007-02-08 Isp Investments Inc. Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
US20080085315A1 (en) * 2006-10-10 2008-04-10 John Alfred Doney Amorphous ezetimibe and the production thereof
US20080152717A1 (en) * 2006-12-14 2008-06-26 Isp Investments, Inc. Amorphous valsartan and the production thereof
US8613946B2 (en) * 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
WO2008092046A2 (en) * 2007-01-26 2008-07-31 Isp Investments Inc. Amorphous oxcarbazepine and the production thereof
CN101622302B (zh) * 2007-01-26 2013-01-23 Isp投资公司 生产喷雾干燥产品的制剂工艺方法
US20100209957A1 (en) * 2008-06-20 2010-08-19 Genvault Corporation Biosample storage devices and methods of use thereof
WO2010031007A2 (en) 2008-09-12 2010-03-18 Genvault Corporation Matrices and media for storage and stabilization of biomolecules
US8939388B1 (en) 2010-09-27 2015-01-27 ZoomEssence, Inc. Methods and apparatus for low heat spray drying
US9332776B1 (en) 2010-09-27 2016-05-10 ZoomEssence, Inc. Methods and apparatus for low heat spray drying
US20120222979A1 (en) 2011-03-04 2012-09-06 Elwha LLC, a limited liability company of the State of Delaware Glassy compositions
SI2741740T1 (sl) * 2011-08-12 2017-08-31 Merial, Inc. Vakuumsko konzerviranje bioloških proizvodov, zlasti cepiv
PL2790681T5 (pl) 2011-11-18 2024-02-05 Regeneron Pharmaceuticals, Inc. Sposób otrzymywania farmaceutycznej postaci użytkowej o przedłużonym uwalnianiu zawierającej mikrocząstki białkowe powlekane polimerem z wykorzystaniem suszenia rozpyłowego
FR2988091B1 (fr) * 2012-03-16 2014-08-15 Innov Ia 3I Compositions pulverulentes d'un complexe entre un acide et un metal et leur procede de preparation
CA2904077A1 (en) * 2013-03-15 2014-09-25 Psivida Us, Inc. Bioerodible silicon-based compositions for delivery of therapeutic agents
MX2018005384A (es) * 2015-12-16 2018-08-16 Regeneron Pharma Composiciones y metodos para fabricar microparticulas de proteina.
RU2659685C1 (ru) * 2017-03-27 2018-07-03 Федеральное государственное бюджетное учреждение "48 Центральный научно-исследовательский институт" Министерства обороны Российской Федерации Способ сорбционно-вакуумного высушивания жидких термолабильных биологически активных материалов
WO2019028446A1 (en) 2017-08-04 2019-02-07 ZoomEssence, Inc. APPARATUS AND METHOD FOR HIGH-PERFORMANCE SPRAY DRYING
US10486173B2 (en) 2017-08-04 2019-11-26 ZoomEssence, Inc. Ultrahigh efficiency spray drying apparatus and process
US9861945B1 (en) 2017-08-04 2018-01-09 ZoomEssence, Inc. Ultrahigh efficiency spray drying apparatus and process
US9993787B1 (en) 2017-08-04 2018-06-12 ZoomEssence, Inc. Ultrahigh efficiency spray drying apparatus and process
US10155234B1 (en) 2017-08-04 2018-12-18 ZoomEssence, Inc. Ultrahigh efficiency spray drying apparatus and process
US10569244B2 (en) 2018-04-28 2020-02-25 ZoomEssence, Inc. Low temperature spray drying of carrier-free compositions
CN114797135B (zh) * 2022-06-29 2022-11-18 四川富临新能源科技有限公司 喷雾干燥法制备锂离子电池活性材料超细粉的设备和方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330749A (en) * 1958-02-11 1967-07-11 Takeda Chemical Industries Ltd Process for treating amino acid solution
US3281216A (en) * 1961-11-03 1966-10-25 Nalco Chemical Co Method of producing amorphous saltfree silica powder capable of forming a sol in aqueous lower alkyl amine solutions
BE759520A (fr) * 1969-11-28 1971-04-30 Aspro Nicholas Ltd Compositions d'aspirine
JPS60258125A (ja) 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
EP0229810B1 (en) 1985-07-09 1991-10-16 Quadrant Bioresources Limited Protection of proteins and the like
JPH0678226B2 (ja) * 1985-12-11 1994-10-05 株式会社林原生物化学研究所 脱水医薬品とその製造方法
US4734401A (en) 1986-03-17 1988-03-29 W. R. Grace & Co. Process for spray drying amino acid compositions
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
GB8903593D0 (en) * 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
GB9010742D0 (en) 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
US5200399A (en) 1990-09-14 1993-04-06 Boyce Thompson Institute For Plant Research, Inc. Method of protecting biological materials from destructive reactions in the dry state
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
DE4141351A1 (de) 1991-12-14 1993-06-17 Basf Ag Stabile pulverfoermige vitamin- und/oder carotinoid-praeparate und verfahren zu deren herstellung
US5955448A (en) * 1994-08-19 1999-09-21 Quadrant Holdings Cambridge Limited Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
FR2719479B1 (fr) * 1994-05-04 1996-07-26 Sanofi Elf Formulation stable lyophilisée comprenant une protéine: kit de dosage.
IL116085A (en) * 1994-12-16 1999-12-31 Ortho Pharma Corp Spray dried erythropoietin
CA2218074C (en) * 1995-04-14 2002-10-08 Mohammed Eljamal Powdered pharmaceutical formulations having improved dispersibility
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
EP0913177A1 (de) * 1997-11-03 1999-05-06 Roche Diagnostics GmbH Verfahren zur Herstellung trockener, amorpher Produkte enthaltend biologisch aktive Materialien mittels Konvektionstrocknung, insbesondere Sprühtrocknung

Also Published As

Publication number Publication date
PL329467A1 (en) 1999-05-10
US6689755B1 (en) 2004-02-10
BR9804739A (pt) 1999-11-09
NO985096L (no) 1999-05-04
JPH11228389A (ja) 1999-08-24
NO326204B1 (no) 2008-10-20
IL126828A0 (en) 1999-08-17
NO985096D0 (no) 1998-11-02
JP2010163456A (ja) 2010-07-29
SG66499A1 (en) 2002-04-16
HU9802516D0 (en) 1999-01-28
PE127199A1 (es) 1999-12-14
HRP980575A2 (en) 1999-06-30
AR015998A1 (es) 2001-05-30
NZ332596A (en) 2000-12-22
HRP980575B1 (en) 2002-06-30
CA2253154A1 (en) 1999-05-03
MA26561A1 (fr) 2004-12-20
AU743232B2 (en) 2002-01-24
KR19990044951A (ko) 1999-06-25
CA2253154C (en) 2008-07-08
CN1163288C (zh) 2004-08-25
YU49598A (sh) 2001-07-10
RU2233105C2 (ru) 2004-07-27
CN1222403A (zh) 1999-07-14
PL196456B1 (pl) 2008-01-31
HK1020689A1 (en) 2000-05-19
ZA9810002B (en) 1999-05-03
KR100629378B1 (ko) 2007-03-02
TR199802204A3 (tr) 1999-05-21
MY118853A (en) 2005-01-31
SA99191068B1 (ar) 2006-04-04
AU9045998A (en) 1999-05-20
HU221346B1 (en) 2002-09-28
CZ348798A3 (cs) 1999-05-12
EP0913177A1 (de) 1999-05-06
CZ297917B6 (cs) 2007-04-25
TR199802204A2 (xx) 1999-05-21
HUP9802516A2 (hu) 1999-07-28
TW575433B (en) 2004-02-11
HUP9802516A3 (en) 2000-05-29

Similar Documents

Publication Publication Date Title
ID21204A (id) Proses pembuatan produk-produk amorf dengan bantuan pengeringan konveksi
NO994771D0 (no) FremgangsmÕte ved fremstilling av oligosakkarider
TR199600792A2 (tr) Dihaloazolopirimidinlerin hazirlanmasina yönelik proses.
NO983766D0 (no) FremgangsmÕte til fremstilling av N-acetyl-D-glukosamin
ID26102A (id) Proses pembuatan senyawa-senyawa stilbena
ID23963A (id) Proses pembuatan vinil asetat
NO20000189L (no) Fremgangsmõte for fremstilling av heparin
ID22398A (id) Proses pembuatan turunan-turunan tiazol
NO20024059D0 (no) Fremgangsmåte for fremstilling av et oksazolyletanolderivat
NO20003454L (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
ID21384A (id) Proses polimerisasi pasta etilena
ID22222A (id) Proses pembuatan tiazolidinadiona tersubstitusi
NO993912D0 (no) Fremgangsmåte for fremstilling av eprosartan
NO20000933D0 (no) Fremgangsmåte for fremstilling av polymer
ID29251A (id) Produk kertas tisu, dan proses pembuatan produk tersebut
NO20001777L (no) Fremgangsmate for fremstilling av substituerte 4-fenyl-4-cyanocykloheksankarboksylsyrer
NO993913D0 (no) Fremgangsmåte for fremstilling av eprosartan
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO985119D0 (no) FremgangsmÕte for fremstilling av dypp-belagte artikler
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
NO20001793L (no) FremgangsmÕte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
ID20277A (id) Proses pembuatan